<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel>
    <title>Curetis AG</title>
    <link>http://www.curetis.com/</link>
  <description>Beschreibung meines Angebots</description><language>de</language><image>
    <title>Curetis AG</title>
    <url>http://www.curetis.com/fileadmin/templates/mein_rss.gif</url>
    <link>http://www.curetis.com/</link>
  <width></width><height></height><description>Beschreibung meines Angebots</description></image><generator>TYPO3 - get.content.right</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><lastBuildDate>Mon, 14 May 2012 15:58:00 +0200</lastBuildDate><item>
  <title>Press Release 5/2012</title>
  <link>http://www.curetis.com/news-media/news/rss-singleview.html?tx_ttnews%5Btt_news%5D=43&#38;cHash=d078dfe6239f1ec477ecd50ee388732e</link>
<description>Curetis AG Achieves CE-Marking for Unyvero™ Solution and Initiates Commercialization</description><content:encoded><![CDATA[
  <h3></h3>
  <h3>Curetis AG Achieves CE-Marking for Unyvero™ Solution and Initiates Commercialization</h3>
  Successful completion of performance evaluation study; <br /> CE Mark for Unyvero<sup>™</sup> instrument system and pneumonia application
  <link fileadmin/curetis/media/struktur/News_Media/Press_Releases/20120512_CuretisAGAchievesCE_Marking.pdf>read more</link>
]]></content:encoded><category>News</category>
<pubDate>Mon, 14 May 2012 15:58:00 +0200</pubDate>
</item><item>
<title>BioCapital 2012</title>
<link>http://www.curetis.com/news-media/news/rss-singleview.html?tx_ttnews%5Btt_news%5D=34&#38;cHash=dff50a8052a2c56c60f9f34c865a6edb</link>
<description>BioCapital, Amsterdam, NL - 19 April 2012</description><content:encoded><![CDATA[]]></content:encoded><category>Events</category>
<pubDate>Thu, 19 Apr 2012 09:00:00 +0200</pubDate>
</item><item>
<title>ECCMID 2012</title>
<link>http://www.curetis.com/news-media/news/rss-singleview.html?tx_ttnews%5Btt_news%5D=33&#38;cHash=e5382ea0a2a2d775791956962a3c0838</link>
<description>ECCMID, London, UK - 31 March to 3 April 2012 </description><content:encoded><![CDATA[]]></content:encoded><category>Events</category>
<pubDate>Sat, 31 Mar 2012 09:00:00 +0200</pubDate>
</item><item>
<title>Press Release 3/2012</title>
<link>http://www.curetis.com/news-media/news/rss-singleview.html?tx_ttnews%5Btt_news%5D=40&#38;cHash=eeb92323c576fed9541fca62615152e2</link>
<description>Curetis AG to Present Its Unyvero™ System for Pneumonia Diagnostics.</description><content:encoded>
<![CDATA[
Demonstration supported by symposium on bacterial pneumonia<br />and emerging antibiotic resistance at the 22nd European Congress<br />of Clinical Microbiology and Infectious Diseases (ECCMID)
<link fileadmin/curetis/media/struktur/News_Media/Press_Releases/20120320CuretisAGtopresentUnyvero.pdf>read more</link>
]]></content:encoded>
<category>News</category>
<pubDate>Thu, 22 Mar 2012 00:00:00 +0100</pubDate>
</item>
<item>
<title>MolecularTri Conference</title>
<link>http://www.curetis.com/news-media/news/rss-singleview.html?tx_ttnews%5Btt_news%5D=32&#38;cHash=611544a8293af565bd0ce7d959a06b18</link>
<description>MolecularTri Conference, San Francisco, CA, USA - 19 to 21 February 2012
</description>
<content:encoded><![CDATA[]]></content:encoded>
<category>Events</category>
<pubDate>Sun, 19 Feb 2012 09:00:00 +0100</pubDate>
</item>
<item>
<title>Curetis AG Initiates Prospective Clinical Trial for Rapid Pneumonia Diagnostics</title>
<link>http://www.curetis.com/news-media/news/rss-singleview.html?tx_ttnews%5Btt_news%5D=39&#38;cHash=0bd1533fb81f4b0e8f1d03fd46d1e74b</link>
<description>Expected CE-marking and launch in Europe in 2012</description>
<content:encoded><![CDATA[Holzgerlingen, Germany, February 6, 2012
Curetis AG, an innovative molecular diagnostics company focusing on the development and commercialization of in-vitro diagnostic products for infectious diseases, today announced the start of a prospective clinical trial of its Unyvero™ System and the Unyvero™ P50 Pneumonia Cartridge in the European Union.
<link fileadmin/curetis/media/struktur/News_Media/Press_Releases/20120216_Curetis_Start_Clinical_Trial_Press_Release_APPROVED.pdf>read more</link>
]]></content:encoded>
<category>News</category>
<pubDate>Thu, 16 Feb 2012 13:54:00 +0100</pubDate>
</item>
<item>
<title>Curetis AG Silver Sponsor of ECCMID 2012</title>
<link>http://www.curetis.com/news-media/news/rss-singleview.html?tx_ttnews%5Btt_news%5D=37&#38;cHash=85002234b00445b5c633a0be62983be7</link>
<description>Curetis AG Silver Sponsor of ECCMID 2012
(European Congress of Clinical Microbiology &amp; Infectious...</description>
<content:encoded><![CDATA[
<span style="LINE-HEIGHT: 115%; FONT-FAMILY: &quot;Calibri&quot;, &quot;sans-serif&quot;; FONT-SIZE: 11pt" lang="EN-US">Curetis AG present at ECCMID 2012, in London, UK from March 31<sup>st</sup> to April 3<sup>rd</sup>.<br /></span>
<b><span lang="EN-US">‘Bacterial pneumonia and emerging antibiotic resistance’</span></b><span lang="EN-US"> will be the theme of a Curetis-sponsored Integrated Symposium held on April 1<sup>st</sup> at 4 p.m..<br /><br /></span>
<span lang="EN-US">The workshop will be chaired by Professor Christine Ginocchio (New York) and Prof. Keith Klugman&nbsp;</span>(Atlanta). &nbsp;Prof. Christine Ginocchio (New York), Prof. Jean-Louis Vincent (Brussels), Prof. David Livermore (London), Prof. Ingo Autenrieth&nbsp;(Tübingen) and Prof. Antoni Torres&nbsp;(Barcelona) will discuss the medical and economic burden of pneumonia, its causing pathogens, their respective antibiotic resistances, and the relevance of multiplexed molecular diagnostic testing in lower respiratory tract infections.
<span lang="EN-US">You are kindly invited to attend the Integrated Symposium and learn more about Pneumonia on <b>Sunday April 1<sup>st</sup> 2012 at 4 p.m. to 6 p.m. in Capital Suite H, 3<sup>rd</sup> floor.</b><br /><br /></span>
<span lang="EN-US">After the Symposium, Curetis will celebrate the <b>Unveiling of its Unyvero™ Solution</b> with a German wine and finger food reception at<b> the South Gallery Meeting Rooms 25/26.</b></span> Please join us at <b>6 p.m.</b>!<br /><br />
If you need further information on our Unyvero™ Solution, please visit our team at booth No. 213.]]></content:encoded>
<category>News</category>
<pubDate>Wed, 08 Feb 2012 12:21:00 +0100</pubDate>
</item>
<item>
<title>Collaboration Agreement with Sanofi Pasteur</title>
<link>http://www.curetis.com/news-media/news/rss-singleview.html?tx_ttnews%5Btt_news%5D=35&#38;cHash=4ab572fef3675581e0be3e7643cfcc7f</link>
<description>Curetis and Sanofi Pasteur Sign Collaboration Agreement</description>
<content:encoded><![CDATA[
Curetis and Sanofi Pasteur have signed a collaboration agreement for the potential use of the Unyvero platform in a future global clinical trial.]]></content:encoded>
<category>News</category>
<pubDate>Tue, 13 Dec 2011 09:00:00 +0100</pubDate>
</item>
<item>
<title>Director Sales</title>
<link>http://www.curetis.com/news-media/news/rss-singleview.html?tx_ttnews%5Btt_news%5D=36&#38;cHash=e0ec1ea661fca7d5b42a8671952a96d4</link>
<description>Curetis AG hires Dr. Klaus Brinkmann as Director Sales</description>
<content:encoded><![CDATA[
<link fileadmin/curetis/media/struktur/News_Media/Press_Releases/20111213_Curetis_Appointment_Klaus_Brinkmann_EN_final_APPROVED_CLEAN.pdf>read more</link>]]></content:encoded>
<category>News</category>
			
			
			<pubDate>Tue, 13 Dec 2011 08:00:00 +0100</pubDate>
			
		</item>
		
		<item>
			<title>Press Release 10/2011</title>
			<link>http://www.curetis.com/news-media/news/rss-singleview.html?tx_ttnews%5Btt_news%5D=29&#38;cHash=938eaffd4d342e983375cefe3dbd83f1</link>
			<description>Curetis AG attracts Forbion and Roche as new investors</description>
			<content:encoded><![CDATA[
Series A financing round expanded to €34.1 million
<link fileadmin/curetis/media/struktur/News_Media/Press_Releases/20111026_Curetis_Financing_ENGL_V1.0R_.pdf>read more</link>]]></content:encoded>
			<category>News</category>
			
			
			<pubDate>Wed, 26 Oct 2011 10:00:00 +0200</pubDate>
			
		</item>
		
	</channel>
</rss>
